These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 25975105)
21. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy]. Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233 [TBL] [Abstract][Full Text] [Related]
22. [Experimental evaluation of reamberin and cytoflavin effects on the course and outcome of acute burn injury]. Zinov'ev EV; Nesterov IuV; Lagvilava TO Eksp Klin Farmakol; 2013; 76(4):39-44. PubMed ID: 23762989 [TBL] [Abstract][Full Text] [Related]
23. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy]. Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423 [TBL] [Abstract][Full Text] [Related]
24. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis]. Kosinets VA Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286 [TBL] [Abstract][Full Text] [Related]
25. [Prevention of cognitive dysfunction in elderly cancer patients operated on the pelvic organs in conditions of multimodal anesthesia]. Tumanyan SV; Shepelenko AV; Chekmezova SA Khirurgiia (Mosk); 2018; (11):44-48. PubMed ID: 30531753 [TBL] [Abstract][Full Text] [Related]
26. [Intraoperative cerebroprotection in total intravenous anesthesia in children of school age]. Ovezov AM; Panteleeva MV; Lugovoy AV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):28-33. PubMed ID: 29171485 [TBL] [Abstract][Full Text] [Related]
28. [Cytoflavin effect on locomotor and psychoemotional status in physiological and pathological aging.]. Sokolova YO; Teply DL; Anisimov VN; Bazhanova ED Adv Gerontol; 2020; 33(2):367-372. PubMed ID: 32593254 [TBL] [Abstract][Full Text] [Related]
29. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414 [TBL] [Abstract][Full Text] [Related]
30. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries]. Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316 [TBL] [Abstract][Full Text] [Related]
31. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia]. Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732 [TBL] [Abstract][Full Text] [Related]
32. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency]. Beĭn BN; Dravert NE Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551 [TBL] [Abstract][Full Text] [Related]
34. [MORPHOLOGICAL CHANGES IN RAT MYOCARDIUM EXPOSED TO HEMIC HYPOXIA AND TREATED WITH CYTOFLAVIN.]. Zadnipryanyi IV; Tret'yakova OS; Sataeva TP Eksp Klin Farmakol; 2016 Aug; 79(5):20-25. PubMed ID: 29782775 [TBL] [Abstract][Full Text] [Related]
35. Cardio and cytoprotective effect of cytoflavin in terms of experimental perinatal hemic hypoxia. Zadnipryanyy IV; Tretiakova OS; Sataieva TP Patol Fiziol Eksp Ter; 2016; 60(4):64-71. PubMed ID: 29244925 [TBL] [Abstract][Full Text] [Related]
36. [The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome]. Erkebaeva SK; Nurguzhaev ES; Gafurov BG; Tuksanbaeva GU Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):32-6. PubMed ID: 23257743 [TBL] [Abstract][Full Text] [Related]
37. [EFFECT OF CITOFLAVIN ON THE PARAMETERS OF LIPID PEROXIDATION IN BLOOD PLASMA OF RATS UNDER COLD STRESS CONDITIONS.]. Dorovskikh VA; Li ON; Simonova NV; Shtarberg MA Eksp Klin Farmakol; 2016; 79(7):29-34. PubMed ID: 29782743 [TBL] [Abstract][Full Text] [Related]
38. [Characteristics of the regulation of neurotrophic mechanisms in ischemic stroke]. Tsygan NV; Trashkov AP; Yakovleva VA; Malkova VM; Gracheva EV; Kovalenko AL; Vasiliev AG Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):112-116. PubMed ID: 26356524 [TBL] [Abstract][Full Text] [Related]
39. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS]. Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]. Isakov VA; Kovalenko AL; Turkin VV; Makarov VI Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]